Skip to content

Author

Sarad Pawar Naik Bukke

We have 5 of 91 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

Microbial pigments as next generation food colorants: unraveling structure, function relationships and biotechnological innovations

Microbial pigments have been emerged as a promising next-generation food colourants because of increasing consumer demands for sustainable, natural, and health-promoting actions. Unlike plant-derived pigments, microbial pigments provide benefits like scalability, rapid production, and consistent yield independent of se...

A. H. Duwan, Achsah Rajendran Startha Christabel, A. Raja et al. · 0 citations
Review Open access Sep 2026

Molecular insights into triazole-based compounds for triple-negative breast cancer treatment

Abstract Triple-negative breast cancer (TNBC) is an aggressive breast cancer subtype lacking oestrogen, progesterone, and HER2 receptors, thus limiting the effectiveness of targeted therapies. Triazole compounds have emerged as promising anticancer agents because of their structural versatility, chemical stability, and...

Ahamed Vilangalil, Sindhu Priya E. S, Sarad Pawar Naik Bukke et al. · 0 citations
Open access Sep 2026

Prevalence and factors associated with antihypertensive drug therapy problems among hypertensive patients, southwestern Uganda: a multicenter cross-sectional study

The findings revealed that over a half of the participants had antihypertensive related DTPs, and the most common DTP was dosage too low indicating a need for dosage management.

Ampereza Christine, Mohammed H. Alnazeer, Safa A. Abdalla et al. · 0 citations
Review Aug 2026

Engineering innovations for precision medicine: sensors, AI biomarkers, and predictive interventions.

This paper summarizes recent advances in biosensor technologies, AI-derived biomarkers, and predictive frameworks used to help identify patients more accurately, monitor their progress continuously, and receive optimized therapies.

Sarad Pawar Naik Bukke, Chandrashekar Thalluri, Mallikarjun Vasam et al. · 0 citations
Review Aug 2026

Phage and CRISPR based precision antimicrobials: a dual strategy against multidrug-resistant bacteria

This review critically examines bacteriophage-based antimicrobials, CRISPR-Cas therapeutic systems, and their emerging integration as CRISPR-armed phages, highlighting their comparative advantages, current limitations, and future potential as promising targeted antimicrobial approach platforms requiring further clinica...

Anjaneyulu Musini, V. Yata, Sarad Pawar Naik Bukke et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.